...
机译:免疫检查点抑制在败血症中:A相随机,安慰剂控制,单一升序抗腹膜死亡配体1抗体的单一升序研究(BMS-936559)
Washington Univ Sch Med Dept Anesthesiol St Louis MO 63110 USA;
Bristol Myers Squibb Innovat Med Dev Dept Anesthesiol Princeton NJ USA;
Vet Affairs Pittsburgh Healthcare Syst Pittsburgh PA USA;
Univ Pittsburgh Sch Med CRISMA Ctr Dept Crit Care Med Pittsburgh PA USA;
Univ Florida Coll Med Dept Surg Gainesville FL USA;
Ohio State Univ Dept Med Columbus OH 43210 USA;
Emory Univ Dept Med Div Pulm Allergy Crit Care &
Sleep Med Atlanta GA 30322 USA;
Emory Univ Dept Surg Atlanta GA 30322 USA;
Univ Florida Coll Med Dept Surg Gainesville FL USA;
Vet Affairs Pittsburgh Healthcare Syst Pittsburgh PA USA;
Univ Michigan Dept Surg Ann Arbor MI 48109 USA;
Bristol Myers Squibb Innovat Med Dev Dept Anesthesiol Princeton NJ USA;
Bristol Myers Squibb Innovat Med Dev Dept Anesthesiol Princeton NJ USA;
Bristol Myers Squibb Innovat Med Dev Dept Anesthesiol Princeton NJ USA;
Bristol Myers Squibb Innovat Med Dev Dept Anesthesiol Princeton NJ USA;
antiprogrammed cell death-ligand 1 BMS-936559; immune checkpoint inhibition; immunotherapy; sepsis; sepsis-associated immunosuppression;
机译:免疫检查点抑制在败血症中:A相随机,安慰剂控制,单一升序抗腹膜死亡配体1抗体的单一升序研究(BMS-936559)
机译:1阶段,随机,双盲,安慰剂控制的单一上升剂量研究,以研究抗流感B病毒单克隆抗体MHAB5553A,健康志愿者的安全性,耐受性和药代动力学
机译:两阶段1,随机,双盲,安慰剂控制,单一升序研究,探讨了抗流感病毒单克隆抗体,MHAA4549a,健康志愿者的安全性,耐受性和药代动力学
机译:I阶段双盲,安慰剂控制,用合成直接凝血酶抑制剂升序单静脉注射剂量研究,TGN255
机译:1B,双盲,安慰剂控制,并行组,NGM282对结肠转运,胆汁酸痛和患者功能性便秘的粪便脂肪的药物动力学的多剂量研究
机译:一项1期随机双盲安慰剂对照单剂量研究用于研究健康志愿者中抗B型流感病毒单克隆抗体MHAB5553A的安全性耐受性和药代动力学
机译:第1A期随机分类的双盲安慰剂控制的单升升序和在健康成人对象中口服吸入GB002的多升剂量研究